An intriguing relation between atrial fibrillation and contrast-induced nephropathy

[1]  B. Chow,et al.  Drug discontinuation before contrast procedures and the effect on acute kidney injury and other clinical outcomes: a systematic review protocol , 2018, Systematic Reviews.

[2]  E. Kaluski,et al.  Use of carbon dioxide as an intravascular contrast agent: A review of current literature , 2017, World journal of cardiology.

[3]  M. Çetin,et al.  Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction? , 2016, Journal of cardiology.

[4]  C. Peña Gil,et al.  Relation of contrast induced nephropathy to new onset atrial fibrillation in acute coronary syndrome. , 2015, The American journal of cardiology.

[5]  A. Mahfouz,et al.  Contrast-induced Nephropathy , 2013, Heart views : the official journal of the Gulf Heart Association.

[6]  Erdmann Seeliger,et al.  Contrast-induced kidney injury: mechanisms, risk factors, and prevention. , 2012, European heart journal.

[7]  F. Veglia,et al.  N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty , 2006 .

[8]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[9]  B. Gersh,et al.  Epidemiology and natural history of atrial fibrillation: clinical implications. , 2001, Journal of the American College of Cardiology.

[10]  M. Hirai,et al.  Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci. , 2017, Journal of cardiology.